-

Humanetics Corporation to Participate in Benchmark Healthcare Investor Conference This Week

MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation announced today that executive management team members will participate in the Benchmark Company’s 5th Annual Healthcare House Call Virtual Investor Conference this week.

Humanetics to participate in benchmark investor conferrence.

Share

The conference takes place on Thursday, May 29th, and Humanetics will be featured during the 1:30 – 2:10 ET time slot.

About Humanetics Corporation

Humanetics is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs, with a focus on radiation modulators for oncology and medical countermeasures. For more information, visit www.humaneticscorp.com.

Contacts

Ronald J. Zenk
Chief Executive Officer
Humanetics Corporation
952-400-0400

Industry:

Humanetics Corporation

Release Versions
English

Contacts

Ronald J. Zenk
Chief Executive Officer
Humanetics Corporation
952-400-0400

More News From Humanetics Corporation

Humanetics Corporation to Host a Virtual Panel Focused on Unmet Needs in Radiation Oncology and Pulmonology

MINNEAPOLIS--(BUSINESS WIRE)--HUMANETICS CORPORATION TO HOST A VIRTUAL PANEL FOCUSED ON UNMET NEEDS IN RADIATION ONCOLOGY AND PULMONOLOGY...

Humanetics Corporation to Present at Radiation Research Society 71st Annual International Meeting

MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company pioneering novel prophylactic Medical Countermeasures for military and civilian clinical applications, today announced that the Company will be presenting at the 71st Annual International Meeting of the Radiation Research Society being held September 21-24, 2025, at the Hilton Caribe, San Juan, Puerto Rico. Michael D. Kaytor, Ph.D., Vice President of Research and Development at Huma...

Humanetics Corporation to Present at Upcoming Military Medical and Defense Conferences

MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company pioneering novel prophylactic Medical Countermeasures for warfighters, first responders, and others at risk of radiation exposure from nuclear attacks or industrial accidents, today announced that Company scientists and members of the leadership team will be presenting and participating at the following conferences and events: Countering Weapons of Mass Destruction (CWMD) Consortium...
Back to Newsroom